CD24 and medulloblastoma: Significantly higher CD24 expression levels were observed in SHH (p<0.0001), Group 3 (p = 0.0049) and Group 4 (p<0.0001) medulloblastoma subgroups compared with WNT subgroups (Fig 5A).